Apotex

Apotex, founded in 1974, is a prominent Canadian global pharmaceutical company dedicated to producing high-quality, affordable medicines for patients worldwide. Operating within the Pharmaceuticals and Healthcare sectors, Apotex focuses on both generic and innovative pharmaceutical products, ensuring accessibility across international markets. Its commitment extends to developing complex dosage forms and active pharmaceutical ingredients (APIs), underscoring its role as a key player in global health solutions. The company's entrepreneurial spirit drives its mission to provide cost-effective healthcare options.

With a substantial workforce ranging from 5,000-10,000 employees, Apotex operates across 29 locations globally, demonstrating a significant operational footprint. This extensive network supports its mission to deliver essential medicines to diverse patient populations. The company's scale and reach are indicative of its robust infrastructure and commitment to global health. Meet Apotex's team to understand the leadership driving these operations. Its presence spans continents, including North America, with a strong base in Canada.

Apotex generates significant revenue, reported at $2.0B, reflecting its strong market position. The company competes with major global pharmaceutical entities such as Teva, Bristol-Myers Squibb, and Lilly, among others. Its product portfolio includes a wide array of pharmaceuticals, medicines, and APIs, catering to various healthcare needs. Apotex's strategic focus on affordability and quality positions it as a vital contributor to healthcare systems globally, making essential treatments accessible to a broader demographic.